OncoCyte
(NASDAQ:OCX)
$2.61
0.08[3.16%]
Last update: 9:25AM Get Real Time Here
Q4 2023 Earnings were released on Fri Apr 12th, before the market open
The most recent conference call was at 8:00 AM, 4 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

OncoCyte Stock (NASDAQ:OCX), Quotes and News Summary

OncoCyte Stock (NASDAQ: OCX) stock price, news, charts, stock research, profile.

Open$2.560
Close-
Volume / Avg.126.596K / 49.829K
Day Range2.490 - 2.660
52 Wk Range2.080 - 6.800
Market Cap$34.813M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
35
Short Interest
1.87%
Days to Cover19.17

Recent News

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
Avi Kapoor
Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Shares of Medical Properties Trust, Inc. (NYSE: MPW) rose sharply in today’s pre-market trading after the company announced that it sold its majority interest in Utah Hospitals.
Avi Kapoor
Top 3 Health Care Stocks That May Collapse In Q2
As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
1
Nov 23
0
0
0
0
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
1.7
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell
About Oncocyte Corporation
Sector
Health Care
Industry
Biotechnology
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, l...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
OCX
NKGN

FAQ

Q

How do I buy OncoCyte (OCX) stock?

A

You can purchase shares of OncoCyte (NASDAQ: OCX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are OncoCyte's (OCX) competitors?

A

Other companies in OncoCyte’s space includes: NKGen Biotech (NASDAQ:NKGN), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Palatin Techs (AMEX:PTN) and MAIA Biotechnology (AMEX:MAIA).

Q

What is the target price for OncoCyte (OCX) stock?

A

The latest price target for OncoCyte (NASDAQ: OCX) was reported by Benchmark on Monday, April 15, 2024. The analyst firm set a price target for 5.00 expecting OCX to rise to within 12 months (a possible 90.48% upside). 6 analyst firms have reported ratings in the last year.

Q

Current Stock Price for OncoCyte (OCX)?

A

The stock price for OncoCyte (NASDAQ: OCX) is $2.625 last updated Today at April 16, 2024 at 2:38 PM EDT.

Q

Does OncoCyte (OCX) pay a dividend?

A

There are no upcoming dividends for OncoCyte.

Q

When is OncoCyte (NASDAQ:OCX) reporting earnings?

A

OncoCyte’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Q

Is OncoCyte (OCX) going to split?

A

There is no upcoming split for OncoCyte.

Q

What sector and industry does OncoCyte (OCX) operate in?

A

OncoCyte is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch